(MENAFN- Bangladesh Monitor)
Dhaka: Insurance coverage has been made mandatory for all air travellers to and from Nepal effective December 15.
This follows new rules imposed by the country's Civil Aviation Authority to contain the new variant of coronavirus Omicron.
Nepal offers visa on-arrival to those who have taken full dose of vaccination at least 14 days prior to the arrival of Nepal.
To avail the visa-on-arrival, the visitor shall submit the following documents in addition to the regular visa related documents: Covid-19 vaccination certificate showing full does of vaccination with the last does taken at least 14 days prior to arriving in Nepal; Covid-19 test report showing negative result done within last 72 hours of boarding from the departure airport (not required for children below 5 years); confirmation of hotel booked in Nepal; and a printed copy of the online form (International Traveller Online Arrival Form) filled by logging in to ccmc.gov.np.
Travellers without certificate of full doze vaccination are not eligible for visa-one-arrival. They must take visa from the Embassy to enter into Nepal. Such persons require to go for 10 days of hotel quarantine in Kathmandu to the designated hotels. On the 10th day they have to test for Covid-19 in their own expenses and wait till the result. They can leave the hotel if the test result comes negative. Otherwise, if the test report comes positive, they will be sent to the isolation canter or hospital designated by the Ministry of Health and Population of the Government of Nepal.
Currently, Biman Bangladesh Airlines and Himalaya Airlines each operate two weekly flights on Dhaka-Nepal route.
In the wake of global fear of new coronavirus variant Omicron, Nepal has put a ban on entry of passengers arriving from and transiting South Africa, Botswana, Zimbabwe, Namibia, Lesotho, Eswatini, Mozambique, Malawi and Hong Kong.
Travellers who have been to any of these nine countries in past three weeks also will be restricted from entering Nepal.
MENAFN08122021000163011034ID1103325632
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.